• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microb Genom . Integration of bioinformatic tools for the detection of SARS-CoV-2 co-infection cases

tetano

Editor, Senior Moderator
Microb Genom


. 2026 Jan;12(1):001604.
doi: 10.1099/mgen.0.001604.
Integration of bioinformatic tools for the detection of SARS-CoV-2 co-infection cases

Adeliza Mae L Realingo[SUP] 1 [/SUP], Francisco Gerardo M Polotan[SUP] 1 [/SUP], Miguel Francisco B Abulencia[SUP] 1 [/SUP], Roslind Anne R Pantoni[SUP] 1 [/SUP], Jessel Babe G Capin[SUP] 1 [/SUP], Gerald Ivan Sotelo[SUP] 1 [/SUP], Maria Carmen A Corpuz[SUP] 1 [/SUP], Neil Tristan M Yabut[SUP] 1 [/SUP], Saul M Rojas[SUP] 1 [/SUP], Ma Angelica Tujan[SUP] 1 [/SUP], Karen Iana Tomas[SUP] 1 [/SUP], Ardiane Ysabelle Dolor[SUP] 1 [/SUP], Czarina Christelle Alyannah Celis[SUP] 1 [/SUP], Stephen Paul Ortia[SUP] 1 [/SUP], Ezekiel A Melo[SUP] 1 [/SUP], Chelsea Mae M Reyes[SUP] 1 [/SUP], Elijah Miguel P Flores[SUP] 1 [/SUP], Anne Pauline A Alpino[SUP] 1 [/SUP], Aldwin Kim A Penales[SUP] 1 [/SUP], Kathlene Mae C Medina[SUP] 1 [/SUP], Joanna Ina Manalo[SUP] 1 [/SUP], Timothy John R Dizon[SUP] 1 [/SUP], Katie Hampson[SUP] 2 [/SUP], Sandeep Kasaragod[SUP] 2 3 [/SUP], Joseph Hughes[SUP] 3 [/SUP], Kirstyn Brunker[SUP] 2 3 [/SUP]


Affiliations
Abstract

Co-infection with multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, though rare, may have clinical and public health implications, including facilitating variant recombination. Early detection of co-infections is, therefore, crucial. In this study, we report two probable cases of co-infection identified during routine genomic surveillance. Initially suspected as cross-contamination due to the presence of private mutations and nucleotide mixtures flagged by Nextclade and bammix, the samples were re-extracted and re-sequenced after workspace decontamination, yet the anomalies persisted. To investigate further, we developed a bioinformatics pipeline (Katmon) incorporating various tools such as Freyja, with lineage abundance results that illustrated the presence of multiple variants, and VirStrain, which confirmed inconsistent lineage assignments. We also visualized the alternative allele fractions for each lineage-defining mutation and amplicon, showing evidence of two variants, Delta and Omicron, co-existing within a single amplicon. Amplicon sorting effectively separated reads corresponding to the two variants, and the resulting consensus sequences aligned with their respective lineage assignments. These findings suggest that the first sample, PH-RITM-1395, involved a Delta-Omicron co-infection, while the second sample, PH-RITM-4146, probably contains both a co-infection and a recombinant variant. To further support the second sample's recombinant nature, we employed sc2rf, which identified Delta-Omicron breakpoints. Retrospective analysis of 1,078 samples from July 2021 to July 2022, encompassing the period of co-circulation of different variants in the Philippines, flagged four additional co-infection cases, including Delta-Omicron and Beta-Omicron, suggesting a lower bound co-infection prevalence of 0.27% and 0.19%, respectively. Furthermore, the pipeline was used to test previously identified co-infections of different variants from different countries. Our findings underscore the critical importance of real-time genomic surveillance and advanced bioinformatics pipelines in detecting SARS-CoV-2 co-infections and variant recombination.

Keywords: SARS-CoV-2; bioinformatics pipeline; co-infection; genomic surveillance; nucleotide mixtures; recombination.

 
Back
Top